Effect of heparin in the prevention of central vein catheter

The effect of intermediate dose of heparin solution in the prevention of central vein catheter occlusion on ICU admitted patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190905044704N1

Enrollment

150

Registered

2021-08-19

Start date

2021-09-06

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central vein catheters occlution. Complications of other internal prosthetic devices, implants and grafts

Interventions

Intervention 1: Intervention group: The active and inactive lines in the intervention group will be washed every 8 hours with 10 ml of saline solution and then locked with 1.5 ml of heparin solution

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All ICU admitted patients who had 3 functional lumen catheter that insert less than 12 hours

Exclusion criteria

Exclusion criteria: Dialysis and phresis and pulmonary artery catheters and insertable ports Age less than 18 y/o Pregnancy Heparin sensivity and HIT Coagolation system disorder and thrombocytopenia Therapeutic dose of anticoagolant Packed cell or any blood products transfusion TPN If the active lines needed more than 3 time hepparizination were excluded

Design outcomes

Primary

Measure	Time frame
Central vein catheter occlution. Timepoint: Central vein catheters was checked every 8 hours untill 14 days. Method of measurement: Aspiration and infusion.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAsieh Yahyaie

Mashhad University of Medical Sciences

yahyaeia961@mums.ac.ir+98 51 3802 3763

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026